Vivo Bio Tech Limited returned to profitability in the first quarter of FY26, reporting a consolidated net profit of ₹18.76 lakh for the period ended June 30, 2026. This marks a significant recovery from the net loss of ₹516.27 lakh recorded in the quarter ended March 31, 2026. Revenue from operations for the quarter stood at ₹1,427.97 lakh, a slight increase from the ₹1,420.11 lakh reported in the previous quarter.

The Board of Directors approved the unaudited standalone and consolidated financial results during a meeting held on July 13, 2026. The results have been reviewed by the Audit Committee and are subject to a limited review by the Statutory Auditors, M/s. P. Murali & Co., Chartered Accountants. The financial statements were prepared in accordance with the Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013, and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

On a standalone basis, the company reported a net profit of ₹18.43 lakh for Q1FY26, reversing the net loss of ₹543.69 lakh in Q4FY26. Standalone revenue from operations rose to ₹1,413.94 lakh from ₹1,376.72 lakh in the preceding quarter. Total income for the quarter was ₹1,419.48 lakh, while total expenses were reported at ₹1,385.95 lakh.

The consolidated results include the performance of the company's subsidiaries: Vivobio Labs Private Limited, Vivobio Discovery Services Private Limited, Surlogic Life Consultancy Private Limited, and Vivobio Consulting Services Private Limited. The company operates in a single segment, Bio Technology, and therefore segmental reporting is not required.

Earnings per equity share (basic and diluted) for the consolidated results were reported at ₹0.08 for Q1FY26, an improvement from the negative ₹2.52 per share recorded in the previous quarter. The paid-up share capital of the company remained at ₹2,219.06 lakh during the period.

Vivo Bio Tech Ltd shareholders have approved the re-appointment of Mr. Kalyan Ram Mangipudi as Whole-time Director and sanctioned related party transactions involving a promoter appointment and dealings with M/s. Virinchi Limited. The resolutions were passed via a postal ballot process that concluded on July 14, 2026, with the requisite majority as per the scrutinizer's report.

The postal ballot sought shareholder approval for three key resolutions. The first concerned the re-appointment of Mr. Kalyan Ram Mangipudi (DIN: 02012580) as the Whole-time Director of the Company. The second resolution involved a related party transaction to appoint Mrs. Madhavi Latha Kompella, a Promoter, as an Advisor for Strategy & Business Development for a term of five years from October 01, 2026, to September 30, 2031. The third resolution sought approval for material related party transactions with M/s. Virinchi Limited.

Voting Results

The remote e-voting facility was open from June 15, 2026, to July 14, 2026. The scrutinizer, CS Vinay Babu Gade, confirmed that the votes were unblocked on July 14, 2026, in the presence of witnesses. A total of 21,589 shareholders were on the record date of June 05, 2026. The voting results indicated strong support from the public non-institutional shareholders, while promoter votes were not cast.

Scrutinizer's Findings

The scrutinizer's report confirmed that all three resolutions were passed with the required majority. The report noted that there were no invalid votes recorded for any of the resolutions. The voting was conducted entirely through remote e-voting, with no physical polling or postal ballot forms utilized. The results were declared based on the collation of votes provided by the service provider, Central Depository Services (India) Limited (CDSL).

The disclosures were made in compliance with Regulation 30 and 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The detailed voting results and the scrutinizer's report have been made available on the company's website.